Fig. 2From: Systematic combinations of major cannabinoid and terpene contents in Cannabis flower and patient outcomes: a proof-of-concept assessment of the Vigil Index of Cannabis ChemovarsEstimated mean changes in symptom severity for distinct chemovars. Note: The estimated means are adjusted for baseline symptom severity level and total volume of terpenes in each product (bars indicate 95% confidence intervals). The MC62 variant was not represented in the analyses for anxiety/depression due to small sample sizesBack to article page